Dr. Edwin K. Silverman

Dr. Edwin Kepner Silverman is chief of the Channing Division of Network Medicine and a physician at Brigham and Women’s Hospital (BWH). He is also a professor of medicine at Harvard Medical School.He received his medical degree from Washington University School of Medicine. He then completed a residency in internal medicine and a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary medicine.Dr. Silverman’s clinical interests include alpha 1-antitrypsin deficiency, emphysema, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). He has served as a principal investigator of multiple COPD genetics studies funded by the National Institutes of Health, including the NETT Genetics Ancillary Study, the Transcontinental COPD Genetics Study, the Alpha-1 Antitrypsin Genetic Modifiers Study and the COPDGene Study. His research uses a variety of genetic analysis approaches to investigate the genetic influences of complex lung diseases, including integrative genomics, linkage analysis, familial aggregation analysis, rare variant analysis and epigenetic studies. He has authored over 320 peer-reviewed publications and is the recipient of the BWH Kenneth L. Baughman Faculty Mentoring Award.

Dr. Silverman is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, and Pulmonary Fibrosis.

His clinical research consists of co-authoring 509 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Cerebral Hypoxia.